Parties Debate Adequacy of GLP-1 Label Warnings On April 9, lawyers representing the drug makers and plaintiffs involved in the litigation each submitted position papers to Judge Pratter, explaining their differing opinions on the litigation, which will largely focus on whether the label warnings for Ozempic, Mounjaro, Wegovy and Zepbound adequately disclosed the risks of gastroparesis and other intestinal injuries
Overall, we found that CR and DL-fed 3xTg and NTg mice of both sexes showed similar but not identical improvements in body weight and composition, as well as glucose tolerance
Efficacy and safety of switching from the DPP-4 inhibitor sitagliptin to the human GLP-1 analog liraglutide after 52 weeks in metformin-treated patients with type 2 diabetes: a randomized, open-label trial
While the injection pricing is competitive, the advanced IV offerings are geared toward those undergoing intense recovery, detox, or cognitive enhancement programs
Induction of apoptosis by epigallocatechin-3-gallate in human lymphoblastoid B cells
Glutathione (GSH) is a central component of the antioxidant defense system, and disruption of GSH homeostasis can lead to the accumulation of pyroglutamate (PGA), which is detectable in plasma